2seventy Bio, Inc. is a high-risk Pharmaceuticals company based in the United States of America. Specializing in cell and gene therapy, 2seventy Bio is dedicated to developing innovative treatments for cancer. With a risk rating score of 35.9, the company is focused on ESG initiatives in the healthcare industry.